Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2015

01.03.2015 | Breast Oncology

Delay in Diagnosis and Treatment of Symptomatic Breast Cancer in China

verfasst von: Qiang Huo, MD, Chang Cai, MD, Yan Zhang, BS, Xiaoli Kong, MD, PhD, Liyu Jiang, MD, PhD, Tingting Ma, MD, Ning Zhang, MD, Qifeng Yang, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Delay in diagnosis and treatment of cancer may lead to advanced tumor characteristics and poor prognosis. Research and investigation from economically developing countries such as China are warranted to support these conclusions, so we studied the impact on prognosis of delays and factors predicting delay in symptomatic breast cancer patients in China.

Methods

Medical records and follow-up information were collected. Variables including demographic data, and clinical and tumor characteristics, including patient age, menstrual status, residential status, initial symptom, profession, comorbidities, tumor size, lymph node metastasis, distant metastasis, history of breast disease, and family history of breast cancer, were analyzed, as was survival information.

Results

A total of 1,431 women diagnosed with breast cancers between 1998 and 2005 in Qilu Hospital were enrolled and studied. Delays in diagnosis and treatment were correlated with larger tumor size, lymph node metastasis, late tumor stage, and worse disease-free survival, as assessed by multivariate logistic regression and Kaplan–Meier regression models. Patient residential status, initial symptom, menopausal status, and history of breast disease were independent predictors of delay. Stratified multivariate analyses confirmed that age was not associated with delay.

Conclusions

Delay in diagnosis and treatment predicts worse clinical outcomes. Improvement of medical service in rural areas, especially for premenopausal women, can decrease delays and benefit breast cancer patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef
2.
3.
4.
Zurück zum Zitat Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353(9159):1127–31.PubMedCrossRef Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353(9159):1127–31.PubMedCrossRef
5.
Zurück zum Zitat Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.PubMedCrossRef Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.PubMedCrossRef
6.
7.
Zurück zum Zitat McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012;30:4493–500.PubMedCentralPubMedCrossRef McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012;30:4493–500.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Wagner JL, Warneke CL, Mittendorf EA, et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254:119–24.PubMedCrossRef Wagner JL, Warneke CL, Mittendorf EA, et al. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011;254:119–24.PubMedCrossRef
9.
Zurück zum Zitat Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166:2244–52.PubMedCrossRef Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166:2244–52.PubMedCrossRef
10.
Zurück zum Zitat Friedman LC, Kalidas M, Elledge R, et al. Medical and psychosocial predictors of delay in seeking medical consultation for breast symptoms in women in a public sector setting. J Behav Med. 2006;29:327–34.PubMedCrossRef Friedman LC, Kalidas M, Elledge R, et al. Medical and psychosocial predictors of delay in seeking medical consultation for breast symptoms in women in a public sector setting. J Behav Med. 2006;29:327–34.PubMedCrossRef
11.
Zurück zum Zitat Love RR, Duc NB, Baumann LC, et al. Duration of signs and survival in premenopausal women with breast cancer. Breast Cancer Res Treat. 2004;86:117–24.PubMedCrossRef Love RR, Duc NB, Baumann LC, et al. Duration of signs and survival in premenopausal women with breast cancer. Breast Cancer Res Treat. 2004;86:117–24.PubMedCrossRef
12.
Zurück zum Zitat Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med. 1993;36:1521–34.PubMedCrossRef Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med. 1993;36:1521–34.PubMedCrossRef
13.
Zurück zum Zitat Meechan G, Collins J, Petrie KJ. The relationship of symptoms and psychological factors to delay in seeking medical care for breast symptoms. Prev Med. 2003;36:374–8.PubMedCrossRef Meechan G, Collins J, Petrie KJ. The relationship of symptoms and psychological factors to delay in seeking medical care for breast symptoms. Prev Med. 2003;36:374–8.PubMedCrossRef
14.
Zurück zum Zitat Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the “National Survey of NHS Patients: Cancer.” Br J Cancer. 2005;92:1971–5.PubMedCentralPubMedCrossRef Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the “National Survey of NHS Patients: Cancer.” Br J Cancer. 2005;92:1971–5.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Hunter CP, Redmond CK, Chen VW, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993;85:1129–37.PubMedCrossRef Hunter CP, Redmond CK, Chen VW, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993;85:1129–37.PubMedCrossRef
16.
Zurück zum Zitat Loblaw DA, Bezjak A, Bunston T. Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital satisfaction with doctor questionnaire. J Clin Oncol. 1999;17:1931–8.PubMed Loblaw DA, Bezjak A, Bunston T. Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital satisfaction with doctor questionnaire. J Clin Oncol. 1999;17:1931–8.PubMed
17.
Zurück zum Zitat Montella M, Crispo A, D’Aiuto G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001;10:53–9.PubMedCrossRef Montella M, Crispo A, D’Aiuto G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001;10:53–9.PubMedCrossRef
18.
Zurück zum Zitat Kothari A, Fentiman IS. 22. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57:200–3.PubMed Kothari A, Fentiman IS. 22. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57:200–3.PubMed
19.
Zurück zum Zitat Hebert-Croteau N, Freeman CR, Latreille J, Rivard M, Brisson J. A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat. 2004;88:187–96.PubMedCrossRef Hebert-Croteau N, Freeman CR, Latreille J, Rivard M, Brisson J. A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat. 2004;88:187–96.PubMedCrossRef
20.
Zurück zum Zitat Tinkler C, Pegington K, Baldwin R. Breast screening attendance: making better use of an appointment system. J Med Screen. 2001;8:36–8.PubMedCrossRef Tinkler C, Pegington K, Baldwin R. Breast screening attendance: making better use of an appointment system. J Med Screen. 2001;8:36–8.PubMedCrossRef
22.
23.
Zurück zum Zitat Baldwin JT. Appointment system in general practice. Br Med J. 1960;1(Suppl 2868):9–12.PubMed Baldwin JT. Appointment system in general practice. Br Med J. 1960;1(Suppl 2868):9–12.PubMed
24.
Zurück zum Zitat Yu W, Yu X, Hu H, Duan G, Liu Z, Wang Y. Use of hospital appointment registration systems in China: a survey study. Global J Health Sci. 2013;5:193–201.CrossRef Yu W, Yu X, Hu H, Duan G, Liu Z, Wang Y. Use of hospital appointment registration systems in China: a survey study. Global J Health Sci. 2013;5:193–201.CrossRef
25.
Zurück zum Zitat Violence against doctors: why China? Why now? What next? Lancet. 2014;383(9922):1013. Violence against doctors: why China? Why now? What next? Lancet. 2014;383(9922):1013.
27.
Zurück zum Zitat Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst. 2001;93:1563–8.PubMedCrossRef Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst. 2001;93:1563–8.PubMedCrossRef
28.
Zurück zum Zitat Zhang Y, Bu Y, Gao H. Rural-urban disparities of breast cancer patients in China. Med Oncol. 2013;30:387.PubMedCrossRef Zhang Y, Bu Y, Gao H. Rural-urban disparities of breast cancer patients in China. Med Oncol. 2013;30:387.PubMedCrossRef
29.
Metadaten
Titel
Delay in Diagnosis and Treatment of Symptomatic Breast Cancer in China
verfasst von
Qiang Huo, MD
Chang Cai, MD
Yan Zhang, BS
Xiaoli Kong, MD, PhD
Liyu Jiang, MD, PhD
Tingting Ma, MD
Ning Zhang, MD
Qifeng Yang, MD, PhD
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4076-9

Weitere Artikel der Ausgabe 3/2015

Annals of Surgical Oncology 3/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.